Purepac Glucophage XR ANDA Status Could Factor Into Injunction Ruling
Executive Summary
A D.C. federal judge's decision on whether Ivax should be preliminarily enjoined from immediately marketing its generic version of Glucophage XR could hinge on the imminent approvability of Purepac's ANDA for metformin extended-release